Perfusion Imaging Market Research Report - Global Forecast till 2027

Global Perfusion Imaging Market Trends, Growth and Size Analysis by Modality (Computed Tomography (CT Scan), Magnetic Resonance Imaging (MRI) and Nuclear Medicine), Application (Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, Functional Brain Imaging and others) and Region - Forecast till 2027

ID: MRFR/MED/2415-CR | July 2019 | Region: Global | 98 pages

Market Overview:


The perfusion radiology market size is required to enroll a CAGR of 6.34% to arrive at USD 7,745.57 Million by 2024. Perfusion Imaging Market Research Report is a non-obtrusive imaging test that shows how the blood courses through the organs or tissues. This test is utilized for the finding of different constant problems. 


Myocardial perfusion imagingis a non-obtrusive imaging test that shows how the blood moves through the organs or tissues. This test is utilized for the finding of different persistent problems. Developing pervasiveness of cardiovascular and neurological sicknesses and expanding geriatric populace drive the development of the worldwide Perfusion Imaging Market Research Report. For example, according to the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, in 2017, consistently around 795,000 individuals in the US have a stroke where around 610,000 are first or new and 185, 000 are intermittent strokes. Also, headways in innovation are further filling market development. 


Developing cardiovascular and neurological infections and expanding the geriatric populace are pushing the advancement of the worldwide perfusion radiology market size. According to themedical imaging industry statistics, consistently, around 795,000 individuals in the US have a hit wherein around 610,000 of them are first or new and185, 000 are repetitive strokes. Moreover, developments in innovation are further invigorating business sector development. In the year 2019 January, Shimadzu Corporation purchased Core Medical Imaging, Inc. to improve its medical services business in North America. This obtainment supported the organization's traction in the North American market. In March 2018, GE got an endorsement from Health Canada for Signa Premier, a 3.0T MRI framework. This expanded the item arrangement of the myocardial perfusion imaging organization. Australia held a portion of 11.2% in the Asia-Pacific perfusion imaging market in 2018. Additionally, the Middle East and Africa market is required to consistently become attributable to the expanding mindfulness about sicknesses in the district.


COVID-19 Analysis:


The COVID-19 pandemic seriously affects the worldwide economy at different levels and can be seen in the spect myocardial perfusion imagingbusiness. The flourishing business sector of medical services innovative work is required to show a lofty decrease in the deals during the lockdown time frame inferable from the closure of the assembling units, intense deficiency in the stock of crude materials, and nonattendance of possible labor. It very well may be reasoned from the current circumstances achieved by the pandemic that the creation and inventory network exercises have encountered minor obstacles. Notwithstanding, the spect myocardial perfusion imagingmarket is projected to continuously recuperate post-COVID-19, which will introduce appealing freedoms for deals across different areas of the world before long.


Market Dynamics:



  • Drivers


The drivers of the global perfusion imaging market are like increasing prevalence of cardiovascular and respiratory diseases, Rising number of organ transplantations, Growth in the Aging Population, Increasing Incidence of Multiple Organ Failures, Government and NGO, Initiatives to Encourage Organ Donation, Increasing Investments in Cell-Based Research, and Increase in Biologic Manufacturing. 


Lexiscan myocardial perfusion imagingframeworks are utilized to sidestep cardiopulmonary frameworks to treat patients with cardiovascular and respiratory illnesses carefully. Perfusion frameworks, for example, heart-lung machines convey oxygen and eliminate carbon dioxide in patients when the heart and lungs neglect to complete the interaction of blood oxygenation.



  • Opportunities


The global perfusion imaging market opportunities are Increasing Pharmaceutical Research in Emerging Markets and Rising Preference for Continuous Manufacturing.


As per the Perfusion Imaging Market Research Report, the factor impacting the increment in the size of pharma developing business sectors is the up-selling of nearby conventional medications. As a result of maturing populaces and a quick expansion in cost, governments supported generics' utilization in their wellbeing plans. Overall, generics cost just 20% of their marked partners. 



  • Restraints 


Effective restraint of Perfusion Imaging Market Research Report is like the High Cost of Organ Transplantation and Ethical Concerns and High Cost of Cell-Based Research.


As per the Perfusion Imaging Market Research Report,organ transfers are so costly in the US. The normally charged expense of heart relocation is an expected $1,382,400, as indicated by counseling firm Milliman, and different organs aren't a lot less expensive.



  • Challenges


The major challenges, as per the Perfusion Imaging Market Research Report, are the Organ Supply-Demand Gap. 


Since its extension in the last part of the 60s to the present, the measure of relocating performed has expanded gradually yet consistently. Notwithstanding, organs' interest to be relocated has increased at an extensively higher rate making a broadening hole between the interest and supply for organs.



  • Cumulative Growth Analysis


According to the Perfusion Imaging Market Research Report, the rising number of constant sicknesses cases like heart illnesses, liver and kidney infections regularly prompts organs to relocate and is one of the significant drivers of the worldwide perfusion market. Besides, rising instances of organ disappointment because of different factors like ill-advised eating routine, smoking, and liquor utilization have prompted the interest in compelling perfusion frameworks. 


The worldwide lexiscan myocardial perfusion imaging market is developing consistently and is relied upon to proceed with its development during the conjecture time frame. The worldwide perfusion radiology market reportis required to develop at the CAGR of 4.1% during the conjecture time frame and is assessed to stretch around USD 1,527 million by 2023.


Technology Analysis


Advancement in innovation has furnished the present organizations with diverse benefits bringing about day by day financial movements. According to aperfusion imaging industry analysis, an organization needs to understand the examples of market developments to plan better. An effective procedure offers the organizations a head start in arranging and an edge over the contenders.


Segment Overview:



  • By Division by application


The Perfusion Imaging Market Research Reportis divided into cardiopulmonary perfusion frameworks, cell perfusion frameworks, and ex vivo organ perfusion. The Perfusion Imaging Market Research Reportframeworks portion represented the biggest portion of the worldwide perfusion frameworks market in 2016. A huge portion of this fragment can be ascribed to the expanding predominance of cardiovascular and respiratory infections and the expanding number of organ relocate systems worldwide. 



  • By Division by segment


Based on segment, the Perfusion Imaging Market Research Reportis fragmented into heart-lung machines, oxygenators, supplies, blood vessel channels, siphons, observing frameworks, information the board frameworks, warmer coolers, cannulas, and extras. The oxygenators fragment is relied upon to represent the biggest portion of the worldwide Perfusion Imaging Market Research Reportframeworks market in 2016. The enormous portion of this fragment can be significantly credited to the rising occurrence of cardiopulmonary disappointment. 



  • By Division by method


The Perfusion Imaging Market Research Reportis sectioned into hypothermic machine perfusion and normothermic machine perfusion based on the method. The hypothermic machine perfusion fragment represented the biggest portion of the ex vivo organ perfusion market. High development in this section can be credited to hypothermic machine perfusion's benefits, for example, better long haul unites endurance rates, diminished vasospasm, and capacity to offer metabolic help. 



  • By Division by type


Based on type, the cell Perfusion Imaging Market Research Reportis fragmented into bioreactor perfusion frameworks, microfluidic perfusion frameworks, gravity or pressing factor-driven perfusion frameworks, and little warm-blooded animal organ perfusion frameworks. The bioreactor perfusion frameworks fragment represented the biggest portion of the cell perfusion frameworks market in 2016. This can be credited to the rising interest in organic items. The consistent need to build item yield and decrease creation costs are factors driving bioreactor perfusion frameworks' selection.


Regional Analysis


In light of area, the worldwide Perfusion Imaging Market Research Reportis isolated into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. 


The Americas is relied upon to hold the biggest portion of the worldwide perfusion imaging market. This is attributable to the expanding occurrence pace of cardiovascular infections, cerebrum tumors, and tumor-related angiogenesis, among others, in the district. Europe showed a lot of development in the market because of the developing pervasiveness of neurological issues. Asia-Pacific is assessed to be the quickest developing district in the worldwide market because of the enormous geriatric populace and quickly creating economies like China, India, and South Korea. Australia held a portion of 11.2% in the Asia-Pacific perfusion imaging market in 2018. Likewise, the Middle East and Africa market is required to consistently become inferable from the expanding mindfulness about illnesses in the district.


Competitive Landscape


Key players of the Perfusion Imaging Market Research Reportare:



  • General Electric Company (US)

  • Advantis Medical Imaging (Netherland) 

  • Aetna (US)

  • lantheus Medical Imaging, Inc. (US)

  • Koninklijke Philips NV (Netherlands)

  • Canon Medical Systems Corporation (Japan)

  • Medtronic (Ireland)

  • Siemens (Germany)

  • Bracco Diagnostic, Inc. (Italy)

  • Neusoft Corporation (China)

  • Shimadzu Corporation (Japan)

  • Perimed (US)


Recent Developments



  • In January 2015, Medtronic procured Covidien plc. (Ireland), a producer of medical services items for use in clinical and home settings around the world. This obtaining intends to fortify Medtronic's client base and resolve medical care difficulties with steady item advancement and assimilating innovations. 

  • In October 2015, Sorin converged with Cyberonics Inc (US) to frame a worldwide clinical innovation organization LivaNova PLC (U.K.). 

  • In February 2014, Sorin obtained Bioengineering Laboratories S.p.A. (BEL), a heart medical procedure cannulas maker. This obtaining is relied upon to reinforce Sorin's situation in the cardiovascular cannulas market fragment.


Report Overview:



  • Market overview highlights the global recognition of the perfusion imaging industry analysis

  • Analysis based upon COVID 19

  • Explanation upon the Market Dynamics

  • Value chain analysis for the medical imaging industry statisticsForecast Research Report.

  • Market segmentation overview

  • The regional analysis of the perfusion radiology market report

  • Competitive landscape analysis

  • Recent Developments of Perfusion Imaging Market Research Report


The report highlights perfusion radiology market growth potential in terms of its revenue hike by the end of the forecast years in 2028.


The segmentation table is as follows:


By application



  • Lungs

  • Heart

  • Liver

  • Kidneys and others


By device type



  • Hypothermic machine perfusion

  • Normothermic machine perfusion and others


By end-user



  • Hospital

  • Specialty clinics

  • Medical research centers

  • Academic institutes, and others.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 7,745.57 Million
  CAGR   6.34% (2019-2024)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Modality, Application and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   General Electric Company (US), Advantis Medical Imaging (Netherland) , Aetna (US), lantheus Medical Imaging, Inc. (US), Koninklijke Philips NV (Netherlands), Canon Medical Systems Corporation (Japan), Medtronic (Ireland), Siemens (Germany), Bracco Diagnostic, Inc. (Italy), Neusoft Corporation (China), Shimadzu Corporation (Japan), Perimed (US)
  Key Market Opportunities   Increasing Pharmaceutical Research in Emerging Markets and Rising Preference for Continuous Manufacturing.
  Key Market Drivers

  • Increasing prevalence of cardiovascular and respiratory diseases
  • Rising number of organ transplantations


  • Frequently Asked Questions (FAQ) :


    Perfusion Imaging Market is projected to grow at a 6.34% CAGR between 2020-2027.

    Perfusion Imaging Market predicted to touch USD 7,745.57 million by 2023.

    The Americas is expected to dominate the Perfusion Imaging Market.

    It finds extensive applications in functional brain imaging, ventilation perfusion imaging, and myocardial perfusion imaging.

    Stringent regulatory policies may limit market growth.

    1 Executive Summary

    1.1 Market Attractiveness Analysis 15

    1.1.1 Global Perfusion Imaging Market, By Modality 15

    1.1.2 Global Perfusion Imaging Market, By Application 16

    2 Market Introduction

    2.1 Definition 17

    2.2 Scope Of The Study 17

    2.3 Assumptions & Limitations 17

    2.3.1 Assumptions 17

    2.3.2 Limitations 17

    2.4 Market Structure 18

    3 Research Methodology

    3.1 Research Process 19

    3.2 Primary Research 20

    3.3 Secondary Research 21

    3.4 Market Size Estimation 21

    3.5 Forecast Model 22

    4 Market Dynamics

    4.1 Overview 23

    4.2 Drivers 24

    4.2.1 Growing Prevalence Of Cardiovascular And Neurological Diseases 24

    4.2.2 Increasing Geriatric Population 24

    4.2.3 Advancements In Technology 24

    4.3 Restraints 25

    4.3.1 Stringent Regulatory Policies 25

    4.3.2 Lack Of Awareness For The Use Of Advanced Technologies 25

    4.4 Opportunities 26

    4.4.1 Entering Developing Economies 26

    4.5 Macroeconomic Indicators 26

    5 Market Factor Analysis

    5.1 Value Chain Analysis 27

    5.1.1 R&D And Designing 27

    5.1.2 Manufacturing 27

    5.1.3 Packaging & Assembly 27

    5.1.4 Distribution & Sales 28

    5.1.5 Post-Sales Review 28

    5.2 Porter’s Five Forces Analysis 29

    5.2.1 Bargaining Power Of Suppliers 29

    5.2.2 Bargaining Power Of Buyers 29

    5.2.3 Threat Of New Entrants 30

    5.2.4 Threat Of Substitutes 30

    5.2.5 Intensity Of Rivalry 30

    6 Perfusion Imaging Market, By Modality

    6.1 Overview 31

    6.2 Computed Tomography (CT Scan) 32

    6.3 Magnetic Resonance Imaging (MRI) 33

    6.4 Nuclear Medicine 34

    7 Perfusion Imaging Market, By Application

    7.1 Overview 35

    7.2 Myocardial Perfusion Imaging 36

    7.3 Ventilation Perfusion Imaging 37

    7.4 Functional Brain Imaging 38

    8 Global Perfusion Imaging Market, By Region

    8.1 Overview 39

    8.2 Americas 41

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.2.1 North America 43

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.2.1.1 US 44

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.2.1.2 Canada 45

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.2.2 Latin America 46

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3 Europe 47

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3.1 Western Europe 48

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3.1.1 Germany 50

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3.1.2 France 50

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3.1.3 UK 51

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3.1.4 Italy 52

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3.1.5 Spain 52

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3.1.6 Rest Of Western Europe 53

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.3.2 Eastern Europe 54

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.4 Asia-Pacific 55

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.4.1.1 Japan 56

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.4.1.2 China 57

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.4.1.3 India 58

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.4.1.4 South Korea 58

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.4.1.5 Australia 59

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.4.1.6 Rest Of Asia-Pacific 60

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.5 Middle East & Africa 61

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.5.1 Middle East 62

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    8.5.2 Africa 63

    Perfusion Imaging Market, By Modality

    Perfusion Imaging Market, By Application

    9 Competitive Landscape

    9.1 Overview 64

    9.2 Competitive Benchmarking 65

    9.3 Leading Players In Terms Of Number Of Developments In The Perfusion Imaging Market 66

    9.4 Key Development Analysis 67

    9.4.1 Partnership/Strategic Agreement 67

    9.4.2 Acquisition 68

    9.4.3 Product Approval 68

    9.4.4 Expansion 68

    10 Company Profiles

    10.1 General Electric Company 69

    10.1.1 Company Overview 69

    10.1.2 Financial Overview 69

    10.1.3 Products/Services Offered 70

    10.1.4 Key Developments 70

    10.1.5 SWOT Analysis 70

    10.1.6 Key Strategies 71

    10.2 Siemens 72

    10.2.1 Company Overview 72

    10.2.2 Financial Overview 72

    10.2.3 Products/Services Offered 73

    10.2.4 Key Developments 73

    10.2.5 SWOT Analysis 74

    10.2.6 Key Strategies 74

    10.3 Medtronic 75

    10.3.1 Company Overview 75

    10.3.2 Financial Overview 75

    10.3.3 Products/Services Offered 75

    10.3.4 Key Developments 76

    10.3.5 SWOT Analysis 76

    10.3.6 Key Strategies 76

    10.4 Canon Medical Systems Corporation 77

    10.4.1 Company Overview 77

    10.4.2 Financial Overview 77

    10.4.3 Products/Services Offered 78

    10.4.4 Key Developments 78

    10.4.5 SWOT Analysis 79

    10.4.6 Key Strategies 79

    10.5 Bracco Diagnostic, Inc. 80

    10.5.1 Company Overview 80

    10.5.2 Financial Overview 80

    10.5.3 Products/Services Offered 81

    10.5.4 Key Developments 81

    10.5.5 SWOT Analysis 81

    10.5.6 Key Strategies 81

    10.6 Koninklijke Philips NV 82

    10.6.1 Company Overview 82

    10.6.2 Financial Overview 82

    10.6.3 Products/Services Offered 83

    10.6.4 Key Developments 84

    10.6.5 SWOT Analysis 84

    10.6.6 Key Strategies 84

    10.7 Neusoft Corporation 85

    10.7.1 Company Overview 85

    10.7.2 Financial Overview 85

    10.7.3 Products/Services Offered 86

    10.7.4 Key Developments 86

    10.7.5 SWOT Analysis 86

    10.7.6 Key Strategies 86

    10.8 Lantheus Medical Imaging, Inc. 87

    10.8.1 Company Overview 87

    10.8.2 Financial Overview 87

    10.8.3 Products/Services Offered 88

    10.8.4 Key Developments 88

    10.8.5 SWOT Analysis 88

    10.8.6 Key Strategies 88

    10.9 Shimadzu Corporation 89

    10.9.1 Company Overview 89

    10.9.2 Financial Overview 89

    10.9.3 Products/Services Offered 90

    10.9.4 Key Developments 90

    10.9.5 SWOT Analysis 90

    10.9.6 Key Strategies 90

    10.10 Aetna 91

    10.10.1 Company Overview 91

    10.10.2 Financial Overview 91

    10.10.3 Products/Services Offered 92

    10.10.4 Key Developments 92

    10.10.5 SWOT Analysis 92

    10.10.6 Key Strategies 92

    10.11 Perimed 93

    10.11.1 Company Overview 93

    10.11.2 Financial Overview 93

    10.11.3 Products/Services Offered 93

    10.11.4 Key Developments 93

    10.11.5 SWOT Analysis 93

    10.11.6 Key Strategies 94

    10.12 Advantis Medical Imaging 95

    10.12.1 Company Overview 95

    10.12.2 Financial Overview 95

    10.12.3 Products/Services Offered 95

    10.12.4 Key Developments 95

    10.12.5 SWOT Analysis 95

    10.12.6 Key Strategies 96

    11 Appendix

    11.1 References 97

    11.2 Related Reports 97

    12 List Of Tables

    TABLE 1 PRIMARY INTERVIEWS 16

    TABLE 2 GLOBAL HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 32

    TABLE 3 AMERICAS HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 33

    TABLE 4 NORTH AMERICA HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 33

    TABLE 5 EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 34

    TABLE 6 WESTERN EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 34

    TABLE 7 ASIA-PACIFIC: HEMP BASED PRODUCTS MARKET, BY COUNTRY 2020–2027 (USD MILLION) 35

    TABLE 8 REST OF THE WORLD (ROW) HEMP BASED PRODUCTS MARKET, BY REGION 2020-2027 (USD MILLION) 35

    TABLE 9 GLOBAL HEMP BASED PRODUCTS MARKET , BY INDUSTRIAL APPLICATION, 2020–2027 (USD MILLION) 36

    TABLE 10 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2020–2027 (USD MILLION) 37

    TABLE 11 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2020–2028 (VOLUME) 38

    TABLE 12 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2019–2027 (VOLUME) 38

    TABLE 13 GLOBAL CBD OIL MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 40

    TABLE 14 GLOBAL CBD OIL MARKET, FOR MARIJUANA-DERIVED CBD OIL BY REGION, 2020–2027 (USD MILLION) 41

    TABLE 15 GLOBAL CBD OIL MARKET, FOR HEMP-DERIVED CBD OIL BY REGION, 2020–2027 (USD MILLION) 42

    TABLE 16 GLOBAL CBD OIL MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 44

    TABLE 17 GLOBAL CBD OIL MARKET, FOR PAIN RELIEF BY REGION, 2020–2027 (USD MILLION) 45

    TABLE 18 GLOBAL CBD OIL MARKET, FOR NEUROLOGICAL DISORDERS BY REGION, 2020–2027 (USD MILLION) 46

    TABLE 19 GLOBAL CBD OIL MARKET, FOR FIBROMYALGIA BY REGION, 2020–2027 (USD MILLION) 46

    TABLE 20 GLOBAL CBD OIL MARKET, FOR MOOD DISORDERS BY REGION, 2020–2027 (USD MILLION) 47

    TABLE 21 GLOBAL CBD OIL MARKET, FOR DIABETES BY REGION, 2020–2027 (USD MILLION) 47

    TABLE 22 GLOBAL CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 49

    TABLE 23 GLOBAL CBD OIL MARKET, FOR E-COMMERCE WEBSITES BY REGION 2020–2027 (USD MILLION) 50

    TABLE 24 GLOBAL CBD OIL MARKET, FOR RETAIL PHARMACIES BY REGION 2020–2027 (USD MILLION) 50

    TABLE 25 GLOBAL CBD OIL MARKET, FOR MEDICAL MARIJUANA DISPENSARIES BY REGION 2020–2027 (USD MILLION 51

    TABLE 26 GLOBAL CBD OIL MARKET, FOR HOSPITAL PHARMACIES BY REGION 2020–2027 (USD MILLION 51

    TABLE 27 GLOBAL CBD OIL MARKET, BY REGION 2020–2027 (USD MILLION) 54

    TABLE 28 AMERICAS: CBD OIL MARKET, BY REGION 2020–2027 (USD MILLION) 55

    TABLE 29 AMERICAS: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 55

    TABLE 30 AMERICAS: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 56

    TABLE 31 AMERICAS: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 56

    TABLE 32 NORTH AMERICA: CBD OIL MARKET, BY COUNTRY 2020–2027 (USD MILLION) 57

    TABLE 33 NORTH AMERICA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 57

    TABLE 34 NORTH AMERICA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 58

    TABLE 35 NORTH AMERICA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 58

    TABLE 36 US: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 59

    TABLE 37 US: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 59

    TABLE 38 US: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 60

    TABLE 39 CANADA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 60

    TABLE 40 CANADA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 61

    TABLE 41 CANADA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 61

    TABLE 42 SOUTH AMERICA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 62

    TABLE 43 SOUTH AMERICA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 62

    TABLE 44 SOUTH AMERICA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 63

    TABLE 45 EUROPE: CBD OIL MARKET, BY REGION 2020–2027 (USD MILLION) 64

    TABLE 46 EUROPE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 64

    TABLE 47 EUROPE: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 65

    TABLE 48 EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 65

    TABLE 49 WESTERN EUROPE: CBD OIL MARKET, BY COUNTRY 2020–2027 (USD MILLION) 66

    TABLE 50 WESTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 67

    TABLE 51 WESTERN EUROPE CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 67

    TABLE 52 WESTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 68

    TABLE 53 GERMANY: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 69

    TABLE 54 GERMANY: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 69

    TABLE 55 GERMANY: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 70

    TABLE 56 UK: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 70

    TABLE 57 UK: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 71

    TABLE 58 UK: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 71

    TABLE 59 FRANCE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 72

    TABLE 60 FRANCE: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 72

    TABLE 61 FRANCE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 73

    TABLE 62 SPAIN: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 73

    TABLE 63 SPAIN: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 74

    TABLE 64 SPAIN: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 74

    TABLE 65 ITALY: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 75

    TABLE 66 ITALY: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 75

    TABLE 67 ITALY: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 76

    TABLE 68 REST OF WESTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 76

    TABLE 69 REST OF WESTERN EUROPE: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 77

    TABLE 70 REST OF WESTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 77

    TABLE 71 EASTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 78

    TABLE 72 EASTERN EUROPE: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 78

    TABLE 73 EASTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 79

    TABLE 74 ASIA-PACIFIC: CBD OIL MARKET, BY COUNTRY 2020–2027 (USD MILLION) 80

    TABLE 75 ASIA-PACIFIC: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 81

    TABLE 76 ASIA-PACIFIC: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 81

    TABLE 77 ASIA-PACIFIC: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 82

    TABLE 78 JAPAN: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 82

    TABLE 79 JAPAN: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 83

    TABLE 80 JAPAN: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 83

    TABLE 81 CHINA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 84

    TABLE 82 CHINA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 84

    TABLE 83 CHINA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 85

    TABLE 84 AUSTRALIA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 85

    TABLE 85 AUSTRALIA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 86

    TABLE 86 AUSTRALIA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 86

    TABLE 87 INDIA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 87

    TABLE 88 INDIA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 87

    TABLE 89 INDIA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 88

    TABLE 90 SOUTH KOREA: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 89

    TABLE 91 SOUTH KOREA: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 89

    TABLE 92 SOUTH KOREA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 90

    TABLE 93 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 90

    TABLE 94 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 91

    TABLE 95 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 91

    TABLE 96 REST OF THE WORLD: CBD OIL MARKET, BY REGION 2020–2027 (USD MILLION) 92

    TABLE 97 REST OF THE WORLD: CBD OIL MARKET, BY PRODUCT 2020–2027 (USD MILLION) 92

    TABLE 98 REST OF THE WORLD: CBD OIL MARKET, BY APPLICATION 2020–2027 (USD MILLION) 93

    TABLE 99 REST OF THE WORLD: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2020–2027 (USD MILLION) 93


    13 List Of Figures

    FIGURE 1 GLOBAL CBD OIL MARKET: MARKET STRUCTURE 14

    FIGURE 2 RESEARCH PROCESS 16

    FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 19

    FIGURE 4 MARKET DYNAMICS: ANALYSIS OF GLOBAL CBD OIL MARKET 21

    FIGURE 5 VALUE CHAIN: GLOBAL CBD OIL MARKET 26

    FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CBD OIL MARKET 27

    FIGURE 7 GLOBAL HEMP BASED PRODUCTS MARKET, BY INDUSTRIAL APPLICATION, 2020 (%) 31

    FIGURE 8 GLOBAL HEMP BASED PRODUCTS MARKET, BY HEMP CBD PRODUCT TYPE, 2020 (%) 31

    FIGURE 9 GLOBAL HEMP BASED PRODUCTS MARKET, BY REGION, 2020 & 2027 (USD MILLION) 32

    FIGURE 10 GLOBAL HEMP BASED PRODUCTS MARKET, BY INDUSTRIAL APPLICATION, 2020 & 2027 (USD MILLION) 36

    FIGURE 11 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2020 & 2027 (USD MILLION) 37

    FIGURE 12 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2020 & 2027 (VOLUME) 38

    FIGURE 13 GLOBAL CBD OIL MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 41

    FIGURE 14 GLOBAL CBD OIL MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 45

    FIGURE 15 GLOBAL CBD OIL MARKET, BY DISTRIBUTION CHANNEL, 2020 & 2027 (USD MILLION) 49

    FIGURE 16 GLOBAL CBD OIL MARKET, BY REGION 2020 & 2027 (USD MILLION) 54

    FIGURE 17 AMERICAS: CBD OIL MARKET SHARE, BY REGION 2020 55

    FIGURE 18 NORTH AMERICA: CBD OIL MARKET SHARE, BY COUNTRY 2020 57

    FIGURE 19 EUROPE: CBD OIL MARKET SHARE, BY REGION 2020 64

    FIGURE 20 WESTERN EUROPE: CBD OIL MARKET SHARE, BY COUNTRY 2020 66

    FIGURE 21 ASIA-PACIFIC: CBD OIL MARKET SHARE, BY COUNTRY 2020 80

    FIGURE 22 REST OF THE WORLD: CBD OIL MARKET SHARE, BY REGION 2020 92

    FIGURE 23 GLOBAL CBD OIL MARKET SHARE ANALYSIS, 2020 (%) 95